RIPTIDE THERAPEUTICS LLC - SBIR TOPIC #446 PHASE I -DEVELOPMENT OF SENOTHERAPEUTIC AGENTS FOR CANCER TREATMENT

On Jan 14, 2026, Department of Health and Human Services obligated $400,000 to RIPTIDE THERAPEUTICS LLC for sbir topic #446 phase i -development of senotherapeutic agents for cancer treatment. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 7 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in EVANSTON, IL. The contract is scheduled through Jun 30, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.